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Although PET with 15O-water is the gold standard for imaging cerebral blood flow (CBF), quantification requires measuring the arterial input function (AIF), which is an invasive and noisy procedure. To
circumvent this problem, we propose a noninvasive PET/MRI approach that eliminates the need to measure AIF by using global CBF
determined by phase-contrast (PC) MRI as a reference region. This
approach not only is noninvasive but also involves no additional
imaging time, because PC MRI and 15O-water PET are acquired
simultaneously. The purpose of this study was to test the accuracy
of this hybrid method in an animal model in which AIF was measured directly and CBF was varied by changing the arterial CO2
tension. Methods: PET and MRI data were simultaneously acquired
in juvenile pigs at hypocapnia (n 5 5), normocapnia (n 5 5), and
hypercapnia (n 5 4). CBF was measured by the MRI reference
method and by PET alone using an MRI-compatible blood sampling
system to measure AIF. Results: Global CBF estimates from PC
MRI and 15O-water PET agreed well, with a correlation coefficient of
0.9 and a slope of 0.88. Strong positive correlations (R2 . 0.96)
were also found between regional CBF generated by the PET-only
and the MRI-reference methods. Conclusion: These findings demonstrate the accuracy of this hybrid PET/MRI approach, which
might prove useful in patients for whom obtaining accurate CBF
measurements is challenging.
Key Words: 15O-water; PET; phase-contrast MRI; CBF; cerebral
blood flow; noninvasive PET
J Nucl Med 2018; 59:1329–1334
DOI: 10.2967/jnumed.117.203414

G

iven the critical role that proper regulation of cerebral blood
flow (CBF) plays in maintaining good brain health and function,
there continues to be a search for perfusion imaging techniques
that are both quantitative and minimally invasive. The gold standard for measuring CBF in humans remains PET using radiolabeled water (15O-water) (1). However, quantification requires
measuring the arterial input function (AIF), which not only is an
invasive procedure with a potential risk of complications but also
is sensitive to noise (2–4). An MRI technique, arterial spin labeling, is an attractive noninvasive alternative; in many respects it is
the MRI analog of PET, since it uses labeled water as a flow tracer

(5). Several validation studies have shown reasonable agreement
between CBF measurements from PET and arterial spin labeling
(6–9); however, despite more efficient labeling approaches and
improvements in MRI technologies, the precision of arterial spin
labeling can still be limited by a low signal-to-noise ratio, and its
accuracy is hampered by arterial transit time effects (10,11). These
issues become increasingly important when a low CBF is being
imaged, such as in white matter, older populations, and patients
with cerebrovascular disease (12–14).
Considering these current limitations of arterial spin labeling,
a PET-based approach that does not require invasive arterial
sampling but can still generate quantitative CBF images would
be useful for measuring CBF in challenging populations. One
approach for circumventing arterial catheterization is to extract an
image-derived input function from dynamic PET images (15). The
accuracy of this approach depends on careful correction for partial-volume effects—a task that is particularly challenging when
an image-derived input function is derived from carotid arteries,
given their relatively small size and the limited resolution of PET
scanners (16–18). More recently, there has been a focus on minimizing
partial-volume effects by coregistering anatomic MR images with PET
images to aid with segmenting the feeding arteries (19). The development of hybrid PET/MRI is attractive for this approach because potential registration errors are reduced by simultaneous imaging (20).
An alternative PET/MRI method eliminating the need to measure
AIF would be a reference-tissue approach. That is, CBF in a given
voxel or region of interest can be determined by relating its time–
activity data to those of a reference region with known blood flow.
The concept of using a reference-based method for 15O-water PET
imaging has been previously proposed (21), but this method required that a known value of global CBF be assumed. With PET/
MRI, this assumption is not necessary, given that CBF, either global
or in a chosen reference region, can be simultaneously measured by
an MRI-based perfusion method. This paper presents a variation of
this hybrid approach that uses an estimate of whole-brain CBF
measured by phase-contrast (PC) MRI (22) as a reference region.
The purpose of the study was to evaluate the accuracy of this hybrid
imaging method using an animal model in which global CBF was
varied by manipulating arterial CO2 tension (PaCO2). For validation,
CBF was also determined independently of the PET data by direct
measurement of AIF.
MATERIALS AND METHODS
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Validation Study

Animal experiments were conducted according to the guidelines of
the Canadian Council on Animal Care and approved by the Animal
Use Committee at Western University. Eight female juvenile Duroc
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pigs were obtained from a local supplier (age range, 8–10 wk; mean
weight 6 SD, 19.6 6 3.0 kg). Under 3% isoflurane anesthesia, the
animals were tracheotomized and mechanically ventilated on a mixture of oxygen and medical air. Catheters were inserted into the cephalic veins for 15O-water injections and into the femoral arteries for
intermittent blood sampling, measurement of PaCO2 and arterial O2
tension, monitoring of blood pressure, and measurement of AIF. After
the preparation and the surgical procedures, the animals were transported to the PET/MRI suite on a custom immobilization platform and
allowed to stabilize for approximately 1 h before the experiment
started. While in the scanner, the animals were anesthetized with a
combination of isoflurane (1%–3%) and an intravenous infusion of
propofol (6–25 mL/kg/h). A pulse oximeter was used to monitor arterial oxygen saturation and heart rate. At the end of the experiment,
the animals were euthanized according to the animal care guidelines.

A flow experiment was performed once PaCO2 was considered
stable as confirmed by 2 readings within 2 mm Hg of each other.
The experiment began with a manual intravenous bolus injection of
15O-water (423 6 130 MBq, 8 mL). A saline flush followed (10 mL),
and then dynamic 15O-water PET and PC MRI data were acquired
simultaneously. After data acquisition, PaCO2 was altered to achieve a
different CBF level, and the procedure was repeated after a delay of at
least 20 min to allow sufficient decay of 15O activity and to ensure
PaCO2 had stabilized to its new level. At the end of the 2 conditions,
the pig was transported on an immobilization platform to either a
Revolution CT scanner (GE Healthcare) or a Discovery VCT PET/
CT scanner (GE Healthcare) to obtain a CT-based attenuation correction map (protocols were identical) (slice thickness, 1.25 mm; energy,
140 kV; field of view, 1,024).
PC MRI Acquisition and Postprocessing

Study Protocol

The study consisted of simultaneously collecting 15O-water PET
and PC MRI data. CBF was changed by adjusting the ventilator
breathing rate and tidal volume to vary PaCO2 from hypo- to hypercapnia. For each animal, CBF measurements were obtained under 2 of
3 possible PaCO2 levels (hyper-, normo-, and hypercapnia), which
were randomly selected per experiment. The number of conditions
was limited to 2 per animal because of considerations regarding the
duration of each experiment and blood loss, which was primarily related to measuring AIF. Before and immediately after each CBF measurement, arterial blood samples were collected to record PaCO2. The
experiments were conducted on a 3-T Biograph mMR PET/MRI system using a 12-channel PET-compatible head coil (Siemens GmbH).
15O-water was produced by an onsite cyclotron (PETtrace 800, 16.5
MeV; GE Healthcare) by the (d,n) 14N reaction. Before CBF data
acquisition, sagittal T1-weighted images, which were subsequently
used as an anatomic reference and to create whole-brain masks, were
acquired using a 3-dimensional magnetization-prepared rapid gradientecho sequence (repetition time/echo time [TR/TE], 1,780/2.45 ms;
inversion time, 900 ms; flip angle, 9; field of view, 180 · 180 mm;
176 slices; isotropic voxel size, 0.7 mm3), followed by 3-dimensional
time-of-flight (TOF) MR angiography (TR/TE, 22/3.6 ms; matrix,
320 · 320 · 105; voxel size, 0.8 · 0.8 · 1.5 mm) (Fig. 1). Finally,
to align the CT data used for attenuation correction to the PET data,
ultrashort echo time contrast images were acquired (TR TE/first TE/second,
11.94/0.07/2.46 ms; field of view, 300 · 300 mm; 192 slices; isotropic voxel
size, 1.6 mm3).

FIGURE 1. CBF measurement by PC. (A) Sagittal T1-weighted image
for anatomic reference, with boxed area representing imaging region for
TOF MR angiography. (B) TOF MR angiography, which was used for
planning PC acquisition. (C) Example magnitude image. (D) Example phase
image. Regions of interest on basilar artery (BA) and internal carotid arteries
(ICA) were contoured on magnitude image and copied to phase image.
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At each PaCO2 level, gated PC images were acquired (TR/TE, 34.4/
2.87 ms; matrix, 320 · 320; voxel size, 0.625 · 0.625 · 5 mm;
velocity encoding, 80 cm/s in the through-plane direction (23,24);
8 averages; 8 segments; duration, 7 min) simultaneously with a 15Owater PET acquisition (25).
PC data were converted into global CBF (23,26) using an in-house–
written MATLAB (MathWorks) script. The contours of the basilar and
internal carotid arteries for each segment of the cardiac cycle were
manually delineated on the magnitude image and copied to the phase
image (Fig. 1). Vessels were contoured 3 times to obtain an average
measurement, which was then used to calculate global CBF.
15O-Water

PET Acquisition and Postprocessing

After the 15O-water injection, 5 min of list-mode data were acquired (27). An MRI-compatible automated blood sampling system
(Swisstrace GmbH) was connected to a catheter in a femoral artery
to measure AIF. The sampling system was attached to a pump set to
a withdrawal rate of 5 mL/min, and activity was recorded at a temporal resolution of 1 s. The system was started approximately 15 s
before the injection of 15O-water and continuously recorded 15Owater activity throughout the scan. The tubing connecting the arterial
catheter to the detector was 15 cm long. A calibration experiment
was performed before the study and showed that the effect of dispersion was negligible at the withdrawal rate and tubing length that
were used.
The PET images were reconstructed offline using the Siemens e7tools suite for Biograph mMR data. Raw PET data were corrected for
scatter, random incidences, detector normalization, and data rebinning. Attenuation was corrected using CT-based attenuation correction
maps that were rescaled to the annihilation emission energy (511 keV)
(28) and aligned to the ultrashort echo time images. PET data were
reconstructed into 37 dynamic frames (3 s · 20, 5 s · 6, 15 s · 6, 30 s
· 5) using 3-dimensional ordered-subset expectation maximization
with 4 iterations and 21 subsets (29). The reconstructed PET images
(matrix size, 344 · 344 · 127; voxel size, 0.8 · 0.8 · 2 mm; zoom
factor, 2.5) were smoothed by a 6-mm gaussian filter.
Dynamic PET images were analyzed in 2 ways using an in-house–
developed MATLAB-based program to generate separate sets of CBF
images. First, by the standard PET-only method using the measured
AIF:
ðt
Ci ðtÞ 5 fi Ca ðuÞe2k2 ðt2uÞ du 1 CBVa  Ca ðtÞ;

Eq. 1

0

where k2 is the clearance rate constant, Ca(t) is AIF, and CBVa is
arterial blood volume. The delay between AIF and PET tissue activity
data was corrected by aligning the initial rise (approximately the first
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TABLE 1
Global CBF Measured by PET-Only and MRI-Reference Approach and Regional CBF Regression Parameters at
Each PaCO2 Level
Condition

MRI-reference CBF
(mL/100 g/min)

PET-only CBF
(mL/100 g/min)

Slope

Intercept
(mL/100 g/min)

R2
0.98 ± 0.01

Hypocapnia

36.5 ± 6.6

34.3 ± 6.0

1.14 ± 0.18

−4.9 ± 2.4*

Normocapnia

54.3 ± 6.6

57.5 ± 10.0

1.14 ± 0.28

−9.3 ± 8.7

0.97 ± 0.02

Hypercapnia

92.3 ± 8.4

87.4 ± 10.6

1.28 ± 0.22

−43.5 ± 20.4*

0.96 ± 0.02

*Significantly different from zero (no slopes were significantly different from one).

10 s) of AIF to an image-derived input function derived from the
carotid arteries of the corresponding dynamic PET data. Spill-in and
spill-out corrections were not performed because only the initial appearance of 15O-water was of interest. With the 2 datasets aligned, the
MATLAB routine for nonlinear optimization (fmincon) was used to fit
Equation 1 to the tissue activity curve to generate best-fit estimates of
CBF, k2, and CBV. This analysis was conducted using the whole-brain
time–activity curve for comparison to whole-brain CBF (fwb) from PC
MRI and at the voxel level to generate CBF images.

The MRI-reference region approach for generating CBF images is
given by Equation 2 (21,30):
ÐT

Ci ðtÞdt

0

fi 5
1
fwb

ÐT
0

Cwb ðtÞdt 1 l1

ÐT Ðt
0 0

Cwb ðsÞds dt 2 l1

ÐT Ðt

;

Eq. 2

Ci ðsÞds dt

0 0

where Ci(t) and fi are the tissue 15O-water concentration and CBF,
respectively, in the ith voxel/region; Cwb(t) is the whole-brain tissue
15O-water concentration; and l is the partition coefficient of water. An
important distinction between the PET-only and MRI-reference methods
is that the latter assumes that arterial blood-borne activity has negligible
effects on the calculation of CBF in the ith voxel/region (fi).
Statistics

Agreement between whole-brain CBF measurements from 15O-water
and PC was assessed by linear regression analysis and Bland–Altman
plots. Linear regression was also used to assess spatial agreement between CBF images created by the 2 methods. To minimize the effects of
spatial correlation, the analysis was conducted using large regions of
interest that encompassed cortical tissue, deep gray matter, and cerebellum. These regions of interest were based on T1-weighted images and
were averaged over adjacent slices to minimize spatial correlation in the
axial direction as well. To assess whether the slope and intercept were
significantly different from 1 and 0, respectively, t tests were conducted,
with a P value of less than 0.05 considered significant. For all measurements, mean 6 SD is reported.
RESULTS
Validation Study: Porcine Model

Data were acquired in juvenile pigs at hypocapnia (n 5 5,
PaCO2 5 29.0 6 3.6), normocapnia (n 5 5, PaCO2 5 39.7 6
2.2), and hypercapnia (n 5 4, PaCO2 5 54.3 6 7.3). Each animal
was scanned at 2 arterial CO2 tensions ranging between 23 and
63 mm Hg. For 2 animals, data from one PaCO2 condition was
excluded—because of failure of the blood sampling system in one
animal and unexpected death in the other.
Whole-Brain CBF

FIGURE 2. Whole-brain comparison. (A) Correlation between CBF
measured by 15O-water and PC (n 5 14), with solid line representing
regression line (y 5 0.88x − 7.1 mL/100 g/min) and dashed line representing line of identity. (B) Bland–Altman plot comparing difference (yaxis) and average (x-axis) of 15O-water and PC CBF (n 5 14), with mean
difference and limits of agreement indicated by horizontal lines.

Global CBF measured by the PET-only method and PC MRI at
hypo-, normo-, and hypercapnia is reported in Table 1. Figure 2A
shows a scatterplot correlating whole-brain CBF measured by the
2 imaging modalities. The correlation coefficient (R2 5 0.9) and
linear regression (slope, 0.88; intercept, 7.1) demonstrated a strong
and significant correlation between the variables (P , 0.001).
Furthermore, the intercept and slope were not significantly
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FIGURE 3. CBF (mL/100 g/min) measured by PET-only and MRI-reference approaches from representative set of animals at 3 PaCO2
ranges. T1-weighted MR images are shown on left for anatomic reference. I 5 inferior; S 5 superior.

different from zero and one, respectively (P , 0.05). Bland–Altman analysis demonstrated little systematic bias, indicated by a
mean difference of 0.16 mL/100 g/min (Fig. 2B).
Regional CBF

Representative CBF images generated by the PET-only technique (Eq. 1) and the MRI-reference method (Eq. 2) at each
PaCO2 level are shown in Figure 3. Similar perfusion patterns
were observed with both methods, with higher blood flow evident
in cortical gray matter, thalamus, and cerebellum. At hypercapnia,
the MRI-reference technique tended to yield higher estimates of
CBF in the midbrain regions. Linear regression plots of the regionof-interest–based CBF values from the 2 techniques were generated to assess spatial agreement. Average regression parameters
are summarized in Table 1. Example regional correlation plots at
the 3 arterial CO2 tensions are shown in Figure 4.
DISCUSSION

The goal of this work was to develop a noninvasive 15O-water
PET method of measuring CBF using hybrid imaging to avoid
directly measuring AIF. Simultaneous PET/MRI provides the ability to use a reference-based method because global CBF can be
measured by PC MRI, or alternatively, CBF in a specific brain
region can be measured by arterial spin labeling. For this study, we
chose the former because PC MRI is a fast and relatively simple
technique to implement (31,32). In fact, it is often used in arterial
spin labeling studies as a means of measuring labeling efficiency
(26). Rather than simply normalizing PET activity images by an
MRI measurement of global CBF, a modeling approach initially
proposed by Mejia et al. (21) was implemented to account for the
nonlinearity between PET activity and CBF. The accuracy of the
method was tested in a porcine model because the animals have a
relatively large brain with good gray-matter–to–white-matter contrast, as well as CBF values similar to those of humans (33). In
addition, the use of an animal model enabled the technique to be
evaluated over a wide range of flows (25–110 mL/100 g/min),
which would be difficult to achieve with human participants.
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Average whole-brain CBF values measured at normocapnia
(57.5 6 10.0 and 54.3 6 16.6 mL/100 g/min by PET and PC
MRI, respectively) were in line with previous studies reporting
values of between 45 and 62 mL/100 g/min (33–35). In addition,
strong correlations between CBF values measured by PC MRI and
15O-water PET, both globally and regionally, were found.
Although PC MRI is an established technique for measuring
global CBF (31,32), it has some technical limitations. Suboptimal
imaging plane selection and coarse image resolution can result in
partial-volume errors if voxels contain both moving fluids and
stationary vessel-wall tissue (22,25,36,37). Additionally, the chosen velocity encoding can potentially introduce error: too small a
value will lead to aliasing, whereas too large a value will result in
a poor signal-to-noise ratio (23). To avoid these errors, the imaging plane was carefully based on a maximum-intensity projection
of the TOF MR angiography, and the voxel size was chosen such
that at least 9 voxels covered the lumen of the larger vessels.
Lastly, velocity encoding was set to 80 cm/s (24) in order to
measure both low and high flows at hypo- and hypercapnia, respectively. A recent study comparing CBF measurements from PC
MRI and 15O-water PET in healthy human subjects reported only
a moderate correlation between the 2 techniques and
significantly higher values
from PC MRI—up to a 63%
overestimation (38). This result is in contrast to the current study, in which a strong
correlation was found (slope,
0.88; intercept, 1.7 mL/100
g/min; R2 5 0.9 [Fig. 2A])
with an insignificant systematic
bias of 0.16 6 7.6 mL/100
g/min (Fig. 2B). It is difficult
to know the specific reason for
this difference. A contributing factor may be variability
in CBF between MRI and
PET measurements—a variability that was avoided in
the current study by simultaneous acquisition. The systematic offset observed in the
previous study may have been
caused by phase errors in the
nongated PC sequence due to
flow pulsatility in the feeding
arteries (32). Regardless of the
reason, the discrepancy between the studies highlights
the importance of ensuring the
accuracy of the MRI method
used for calibration.
Having established no significant difference in global FIGURE 4. Regional CBF scatterCBF measured by PC MRI plots in deep gray matter (○), cerebeland 15O-water PET, we ana- lum (●), and cortical gray matter ( )
at hypocapnia (A), normocapnia (B),
lyzed spatial agreement be- and hypercapnia (C). Each plot is gentween CBF maps generated erated using data from one represenby the standard PET-only ap- tative animal. Equation represents
proach and those generated best fit of linear regression model.
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by the proposed MRI-reference method. Linear regression analysis of
the regional CBF maps showed excellent correlations at all capneic
conditions (R2 5 0.96–0.98). Good agreement was found at hypo- and
normocapnia, as indicated by the near-unity regression slopes and
small intercept values (Table 1) and as shown in the representative
CBF maps (Fig. 3). There was less agreement at hypercapnia, as
indicated by the larger regression slope and significant y-intercept
(Fig. 4). These results reflect the differences observed in the CBF
images, particularly in deep gray matter, and indicate a bias between
the methods at higher flow rates. In the MRI-reference method, the
discrepancy at hypercapnia may have been caused by neglect of
blood-borne activity, whose relative contribution will increase with
elevated CBF because of vessel dilation. Simulations (Supplemental
Fig. 1; supplemental materials are available at http://jnm.snmjournals.
org) predicted that this error should be fairly small for an integration
time of 5 min. This insensitivity to the arterial blood activity is
expected because the reference-based method depends only on the
difference in blood volume between a voxel and the reference region.
However, the error in a highly vascularized voxel could be greater if
the ratio of CBV to CBF were greater than the model prediction,
which was based on Ito et al. (39). An alternative explanation could
be cross talk between fitting parameters for the PET-only approach
(i.e., fi and CBVa), which could lead to an underestimation of CBF
at high values.
Although this study demonstrated good agreement between
CBF values from the MRI-reference approach and the gold
standard PET-only approach over a flow range from about 30 to
100 mL/100 g/min, there are some potential limitations. First,
internal dispersion was not included in the PET-only analysis
because an appropriate value for a dispersion time constant is not
known. However, it would likely be less than the 5 s commonly
used in human studies, given the smaller size of these animals
(weight, 20 kg). A second consideration is that the approach to
positioning the PC slice was based on manual planning using TOF
images. Recent studies have implemented automatic planning
schemes that can optimize selection of the imaging plane (36).
CONCLUSION

We believe that our noninvasive hybrid PET/MRI approach
might prove useful in patients for whom obtaining accurate CBF
measurements is challenging by other methods, most notably
arterial spin labeling, because of transit time delays resulting from
significant vascular disease. Eliminating arterial sampling not only
makes the MRI-reference approach minimally invasive but also
avoids noise contributions from AIF and associated errors due to
dispersion and delay.
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